Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-07-18
2006-07-18
Ungar, Susan (Department: 1642)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S070100, C435S320100, C435S325000, C435S252300, C536S023100, C536S023400, C536S023500
Reexamination Certificate
active
07078186
ABSTRACT:
The present invention relates to novel human apoptosis related polypeptides and isolated nucleic acids containing the coding regions of the genes encoding such polypeptides. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human apoptosis related polypeptides. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human apoptosis related polypeptides.
REFERENCES:
patent: 6569662 (2003-05-01), Tang et al.
patent: 2003/0049702 (2003-03-01), Reed et al.
patent: 2003/0064072 (2003-04-01), Rosen et al.
patent: 2003/0109690 (2003-06-01), Ruben
patent: 2003/0165933 (2003-09-01), Tang et al.
patent: 1 201 754 (2002-05-01), None
patent: WO-01/04300 (2001-01-01), None
patent: WO-03/054195 (2003-07-01), None
Miller (1995, FASEB J., vol. 9, pp. 190-199)
Deonarain (1998, Expert Opin. Ther. Pat., vol. 8, pp. 53-69).
Verma (Sep. 1997, Nature, vol. 389, pp. 239-242).
Crystal (1995, Science, vol. 270, pp. 404-410).
Alcivar et al., “DEDD and DEDD2 associate with caspase-8/10 and signal cell death,”Oncogene, 22(2):291-297 (Jan. 16, 2003).
Barnhart et al., “The death effector domain protein family,”Oncogene, 22(53):8634-8644 (Nov. 24, 2003).
GenBank Accession No. NP—579874, Alcivar et al., “death effector domain-containing DNA binding protein 2 [Homo sapiens]” (Oct. 27, 2004).
GenBank Accession No. NM—133328, Lee et al., “Homo sapiensdeath effector domain containing 2 (DEDD2), mRNA” (Oct. 27, 2004).
Geneseq Accession No. ADC79259, Suzu et al., “Human DEDD2 encoding cDNA SEQ ID No.:1” (Jan. 1, 2004).
Hill et al., “Recognition of ERK MAP kinase by PEA-15 reveals a common docking site within the death domain and death effector domain,”EMBO Journal, 21(23):6494-6504 (2002).
Lee et al., “DEDD regulates degradation of intermediate filaments during apoptosis,”J. Cell Biol., 158(6):1051-1066 (Sep. 16, 2002).
Roth et al., “Identification and Characterization of DEDD2, a Death Effector Domain-containing Protein,”J. Biol. Chem., 277(9):7501-7508 (Mar. 1, 2002).
Stegh et al., “DEDD, a novel death effector domain-containing protein, targeted to the nucleolus,”EMBO Journal, 17(20):5974-5986 (Oct. 15, 1998).
Supplementary Partial European Search Report, Application No. EP 00 913925, mailed Oct. 29, 2004.
Zhan et al., “Death effector domain-containing proteins DEDD and FLAME-3 form nuclear complexes with the TFIIIC102 subunit of human transcription factor IIIC,”Cell Death Differ., 9(4):439-447 (Apr. 2002).
Ni Jian
Ruben Steven M.
Young Paul E.
Davis Minh-Tam
Human Genome Sciences Inc.
Human Genome Sciences Inc.
Ungar Susan
LandOfFree
Apoptosis related polynucleotides, polypeptides, and antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apoptosis related polynucleotides, polypeptides, and antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apoptosis related polynucleotides, polypeptides, and antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3607944